Description
The IHC (Immunohistochemistry) test for HER2/neu assesses the expression of the HER2 protein in breast cancer tissues. This test helps determine the appropriate treatment options for patients.
Test Purpose
- Identifies HER2 protein overexpression in breast cancer.
- Guides treatment decisions, particularly the use of targeted therapies like trastuzumab (Herceptin).
Reviews
There are no reviews yet.